SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Nov-24 4:20 PM View: | Seres Therapeutics, Inc. (MCRB) | 18-Nov-24 | Planned Option Sale | 977 | $0.54 | $528.26 | (3%) 33.39K to 32.41K | |
19-Nov-24 4:20 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-Nov-24 | Option Exercise | 2,969 | -- | -- | 10% 30.42K to 33.39K | |
06-Jun-24 4:26 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-24 | Grant | 150,647 | -- | -- | 466% 32.36K to 183.01K | |
17-May-24 8:23 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,968 | -- | -- | 17% 16.99K to 19.96K | |
17-May-24 8:23 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 939 | $0.94 | $882.66 | (5%) 19.96K to 19.02K | |
16-Feb-24 9:21 PM View: | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 4,400 | $1.08 | $4,752.00 | (21%) 21.39K to 16.99K | |
16-Feb-24 9:21 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 11,875 | -- | -- | 125% 9.51K to 21.39K | |
31-Oct-23 9:36 PM View: | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 4,232 | $1.35 | $5,713.20 | (31%) 13.74K to 9.51K | |
31-Oct-23 9:36 PM View: | Seres Therapeutics, Inc. (MCRB) | 27-Oct-23 | Option Exercise | 13,745 | -- | -- | 100% 0 to 13.74K | |
05-Jun-23 4:36 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-23 | Grant | 32,362 | -- | -- | 100% 0 to 32.36K |